The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Regeneron […]

The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Revance

The Gross Law Firm issues the following notice to shareholders of Nextracker Inc. (NASDAQ: NXT). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of NXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Nextracker Inc.

The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Caribou

The Gross Law Firm issues the following notice to shareholders of Transocean Ltd. (NYSE: RIG). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of RIG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/transocean-ltd-loss-submission-form/?id=124345&from=4 CLASS PERIOD:

The Gross Law Firm issues the following notice to shareholders ofAstraZeneca PLC (NASDAQ: AZN). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: AstraZeneca Loss Submission

The Gross Law Firm issues the following notice to shareholders of Capri Holdings Limited (NYSE: CPRI). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of CPRI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Capri

The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/applied-therapeutics-inc-loss-submission-form/?id=124341&from=4 CLASS

The Gross Law Firm issues the following notice to shareholders ofMGP Ingredients, Inc. (NASDAQ: MGPI). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MGPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: MGP Ingredients,

The Gross Law Firm issues the following notice to shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/cassava-sciences-inc-loss-submission-form-2/?id=124339&from=4 CLASS